FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088894076> ?p ?o ?g. }

• W2088894076 abstract "You have accessJournal of UrologyInfections/Inflammation of the Genitourinary Tract: Prostate & Genitalia1 Apr 2014MP16-01 INCREASED RISK OF BLEEDING AT PROCEDURE WITH INTRAVENOUS CEFTRIAXONE PROPHYLAXIS FOR TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY Annika Krystyna, Minakshi Ramchand, Robert Tenney, Tarang Safi, William Matthew Briggs, and Murray David Schwalb Annika KrystynaAnnika Krystyna More articles by this author , Minakshi RamchandMinakshi Ramchand More articles by this author , Robert TenneyRobert Tenney More articles by this author , Tarang SafiTarang Safi More articles by this author , William Matthew BriggsWilliam Matthew Briggs More articles by this author , and Murray David SchwalbMurray David Schwalb More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.574AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Preliminary analysis of 438 men receiving intravenous (IV) ceftriaxone prophylaxis prior to transrectal ultrasound guided prostate biopsy (TRPB) was conducted in an effort to reduce our institutions observed rate of infectious complications with oral ciprofloxacin only. METHODS Men who had TRPB between October 19, 2009 and October 31, 2013 and received 1 or 2 grams of IV ceftriaxone were followed for thirty days after biopsy for complications. Rates were compared to observed complications with oral ciprofloxacin use from January 1, 2007 until October 18, 2009 using the Chi-squared test. The study was approved by the Institutional Review Board. RESULTS Refer to Table 1. CONCLUSIONS Intravenous ceftriaxone prophylaxis prior to TRPB was effective at reducing total infectious complications in our population. There was an increased risk of bleeding at the time of biopsy. Complications were treated clinically with rectal packing and no men required blood transfusion. The mechanism of bleeding via hypoprothrombinemia with IV ceftriaxone use is described by the manufacturer. This is the only trial describing bleeding associated with IV ceftriaxone use prior to TRPB. Table 1. Comparison of IV ceftriaxone and oral ciprofloxacin complications. Complication IV Ceftriaxone Oral Ciprofloxacin P value Bacteremia 0.3% 1.0% 0.4 Febrile UTI 0.3% 2.7% 0.008 Fever 0.5% 4.4% <0.0001 Dysuria 0.3% 2.0% 0.04 Urinary retention 3.0% 3.0% 1.0 Rectal packing at procedure for bleeding 3.6% 0.0% 0.001 Hematospermia 2.1% 0.7% 0.2 Hematuria 4.4% 4.5% 1.0 © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e153 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Annika Krystyna More articles by this author Minakshi Ramchand More articles by this author Robert Tenney More articles by this author Tarang Safi More articles by this author William Matthew Briggs More articles by this author Murray David Schwalb More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ..." @default.
• W2088894076 created "2016-06-24" @default.
• W2088894076 creator A5020056360 @default.
• W2088894076 creator A5029260831 @default.
• W2088894076 creator A5033829473 @default.
• W2088894076 creator A5036403508 @default.
• W2088894076 creator A5066514476 @default.
• W2088894076 creator A5090443496 @default.
• W2088894076 date "2014-04-01" @default.
• W2088894076 modified "2023-09-26" @default.
• W2088894076 title "MP16-01 INCREASED RISK OF BLEEDING AT PROCEDURE WITH INTRAVENOUS CEFTRIAXONE PROPHYLAXIS FOR TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY" @default.
• W2088894076 doi "https://doi.org/10.1016/j.juro.2014.02.574" @default.
• W2088894076 hasPublicationYear "2014" @default.
• W2088894076 type Work @default.
• W2088894076 sameAs 2088894076 @default.
• W2088894076 citedByCount "0" @default.
• W2088894076 crossrefType "journal-article" @default.
• W2088894076 hasAuthorship W2088894076A5020056360 @default.
• W2088894076 hasAuthorship W2088894076A5029260831 @default.
• W2088894076 hasAuthorship W2088894076A5033829473 @default.
• W2088894076 hasAuthorship W2088894076A5036403508 @default.
• W2088894076 hasAuthorship W2088894076A5066514476 @default.
• W2088894076 hasAuthorship W2088894076A5090443496 @default.
• W2088894076 hasConcept C121608353 @default.
• W2088894076 hasConcept C126322002 @default.
• W2088894076 hasConcept C141071460 @default.
• W2088894076 hasConcept C2775934546 @default.
• W2088894076 hasConcept C2776235491 @default.
• W2088894076 hasConcept C2776520383 @default.
• W2088894076 hasConcept C2778512257 @default.
• W2088894076 hasConcept C2781217009 @default.
• W2088894076 hasConcept C2908647359 @default.
• W2088894076 hasConcept C29456083 @default.
• W2088894076 hasConcept C501593827 @default.
• W2088894076 hasConcept C71924100 @default.
• W2088894076 hasConcept C86803240 @default.
• W2088894076 hasConcept C89423630 @default.
• W2088894076 hasConcept C99454951 @default.
• W2088894076 hasConceptScore W2088894076C121608353 @default.
• W2088894076 hasConceptScore W2088894076C126322002 @default.
• W2088894076 hasConceptScore W2088894076C141071460 @default.
• W2088894076 hasConceptScore W2088894076C2775934546 @default.
• W2088894076 hasConceptScore W2088894076C2776235491 @default.
• W2088894076 hasConceptScore W2088894076C2776520383 @default.
• W2088894076 hasConceptScore W2088894076C2778512257 @default.
• W2088894076 hasConceptScore W2088894076C2781217009 @default.
• W2088894076 hasConceptScore W2088894076C2908647359 @default.
• W2088894076 hasConceptScore W2088894076C29456083 @default.
• W2088894076 hasConceptScore W2088894076C501593827 @default.
• W2088894076 hasConceptScore W2088894076C71924100 @default.
• W2088894076 hasConceptScore W2088894076C86803240 @default.
• W2088894076 hasConceptScore W2088894076C89423630 @default.
• W2088894076 hasConceptScore W2088894076C99454951 @default.
• W2088894076 hasIssue "4S" @default.
• W2088894076 hasLocation W20888940761 @default.
• W2088894076 hasOpenAccess W2088894076 @default.
• W2088894076 hasPrimaryLocation W20888940761 @default.
• W2088894076 hasRelatedWork W2024809579 @default.
• W2088894076 hasRelatedWork W2065507218 @default.
• W2088894076 hasRelatedWork W2135251857 @default.
• W2088894076 hasRelatedWork W2360912380 @default.
• W2088894076 hasRelatedWork W2422235399 @default.
• W2088894076 hasRelatedWork W2566665866 @default.
• W2088894076 hasRelatedWork W2735725742 @default.
• W2088894076 hasRelatedWork W3104029563 @default.
• W2088894076 hasRelatedWork W3142703429 @default.
• W2088894076 hasRelatedWork W4220759998 @default.
• W2088894076 hasVolume "191" @default.
• W2088894076 isParatext "false" @default.
• W2088894076 isRetracted "false" @default.
• W2088894076 magId "2088894076" @default.
• W2088894076 workType "article" @default.